Stereotactic interstitial brachytherapy--current concepts and concerns in twenty patients.

Recent advances in imaging and stereotactic techniques have resulted in wider application of interstitial brachytherapy (IBT) for brain tumors. The advantages of brachytherapy alone or in combination with teletherapy have been detailed, and may be responsible for increasing survival time. We report the preliminary results of 20 patients who underwent CT stereotactic IBT for malignant brain tumors. Despite both old and recent evidence about the efficacy of IBT, concerns remain about the proper grade neoplasm, the target, the dose, and the timing for treatment. Current usage of IBT should be limited to centers with both stereotactic and radiotherapeutic expertise, and where the risks and benefits are being investigated.